Fermenta Biotech Ltd

Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, signalling a potential inflection point for investors. Despite a recent sharp price correction, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more favourably against historical averages and peer benchmarks, prompting a reassessment of its price attractiveness within the Pharmaceuticals & Biotechnology sector.

With a decisive surge to Rs 579.65 on 10 Aug 2026, Fermenta Biotech Ltd has reached a fresh 52-week high, marking a remarkable 66.97% gain over the past year. This rally stands in stark contrast to the Sensex’s modest decline of 1.87% during the same period, underscoring the stock’s strong momentum amid a mixed market backdrop.

Extending its recent rally, Fermenta Biotech Ltd touched a fresh all-time high of Rs 577.5 on 10 Aug 2026, marking a significant milestone in its price journey amid strong technical momentum and notable outperformance against the broader market.

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Surging past its previous peaks, Fermenta Biotech Ltd touched a fresh 52-week high of Rs 568 on 7 Aug 2026, marking a remarkable 63.21% gain over the past year. This milestone comes amid a backdrop of strong technical momentum that has propelled the stock well above its key moving averages, signalling robust price strength despite a broadly subdued market environment.

Fermenta Biotech Ltd has reached a significant milestone by touching an all-time high price of Rs 564 on 7 August 2026, reflecting a robust upward trajectory in its stock performance over recent months and years.

With a sustained five-day rally delivering a 22.38% gain, Fermenta Biotech Ltd surged to a fresh 52-week high of Rs 561.15 on 5 Aug 2026, marking a remarkable ascent from its 52-week low of Rs 256.40. This milestone underscores the stock’s robust price momentum amid a broadly positive market backdrop.

Fermenta Biotech Ltd’s stock price surged to a record high of Rs.561.15 on 5 August 2026, marking a significant milestone in the company’s market journey. This new peak reflects a sustained period of strong performance, with the stock outperforming its sector and broader market indices over multiple time frames.

Fermenta Biotech Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating, even as the stock continues to outperform the broader market significantly. With a current price of ₹546.75, close to its 52-week high of ₹551.25, the micro-cap pharmaceutical company’s price-to-earnings (P/E) ratio now stands at 24.22, reflecting a premium relative to its historical averages and many peers in the Pharmaceuticals & Biotechnology sector.

Surging to an intraday peak of Rs 525 on 4 Aug 2026, Fermenta Biotech Ltd has marked a significant milestone by hitting a fresh 52-week high. This achievement caps a four-day rally that has propelled the stock up by 15.74%, outpacing its sector and reflecting a strong technical momentum that has investors and analysts alike taking note.

Fermenta Biotech Ltd, a player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 4 August 2026 by reaching its all-time high stock price of Rs.525. This marks a notable peak in the company’s market performance, reflecting a sustained upward trajectory over recent months.

From a 52-week low of Rs 256.40 to a fresh high of Rs 518.45 on 3 Aug 2026, Fermenta Biotech Ltd has surged 102.4% in the past year, significantly outpacing the Sensex’s decline of 2.43%. This milestone caps a three-day winning streak that has propelled the stock 13.57% higher, underscoring a powerful momentum shift in this Pharmaceuticals & Biotechnology micro-cap.

Fermenta Biotech Ltd, a player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 3 August 2026 by reaching its all-time high price of Rs.518.45. This marks a notable peak in the company’s market performance, reflecting a sustained upward trajectory over recent months and years.

Fermenta Biotech Ltd has reached a significant milestone by touching a new 52-week high of Rs.488 on 31 Jul 2026, marking a notable surge in its stock price and reflecting strong momentum in the Pharmaceuticals & Biotechnology sector.

With a decisive surge to Rs 482.7 on 30 Jul 2026, Fermenta Biotech Ltd has reached a new 52-week high, marking a 23.01% gain over the past year and outpacing the Sensex’s decline of 4.44%. This milestone reflects a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its 52-week low of Rs 256.4.